Abstract:IMPORTANCE Focal ablative irreversible electroporation (IRE) is a therapy that treats only the area of the tumor with the aim of achieving oncological control while reducing treatment-related functional detriment. OBJECTIVE To evaluate the effect of focal vs extended IRE on early oncological control for patients with localized low-and intermediate-risk prostate cancer. DESIGN, SETTING, AND PARTICIPANTS In this randomized clinical trial conducted at 5 centers in Europe, men with localized low-to intermediate-risk prostate cancer were randomized to receive either focal or extended IRE ablation. Data were collected at baseline and at regular intervals after the procedure from June 2015 to January 2020, and data were analyzed from September 2021 to July 2022. MAIN OUTCOMES AND MEASURES Oncological outcome as indicated by presence of clinically significant prostate cancer (International Society of Urological Pathology grade >= 2) on transperineal template-mapping prostate biopsy at 6 months after IRE. Descriptive measures of results from that biopsy included the number and location of positive cores. RESULTS A total of 51 and 55 patients underwent focal and extended IRE, respectively. Median (IQR) age was 64 years (58-67) in the focal ablation group and 64 years (57-68) in the extended ablation group. Median (IQR) follow-up time was 30 months (24-48). Clinically significant prostate cancer was detected in 9 patients (18.8%) in the focal ablation group and 7 patients (13.2%) in the extended ablation group. There was no significant difference in presence of clinically significant prostate cancer between the 2 groups. In the focal ablation group, 17 patients (35.4%) had positive cores outside of the treated area, 3 patients (6.3%) had positive cores in the treated area, and 5 patients (10.4%) had positive cores both in and outside of the treated area. In the extended group, 10 patients (18.9%) had positive cores outside of the treated area, 9 patients (17.0%) had positive cores in the treated area, and 2 patients (3.8%) had positive cores both in and outside of the treated area. Clinically significant cancer was found in the treated area in 5 of 48 patients (10.4%) in the focal ablation group and 5 of 53 patients (9.4%) in the extended ablation group. CONCLUSIONS AND RELEVANCE This study found that focal and extended IRE ablation achieved similar oncological outcomes in men with localized low-or intermediate-risk prostate cancer. Because some patients with intermediate-risk prostate cancer are still candidates for active surveillance, focal therapy may be a promising option for those patients with a high risk of cancer progression.

The Safety and Efficacy of Irreversible Electroporation Versus Tamsulosin in the Treatment of Benign Prostatic Obstruction: Study Protocol and Rationale for a Randomized Controlled Trial

Prostatic artery embolization versus transurethral resection of the prostate in the treatment of benign prostatic hyperplasia: protocol for a non-inferiority clinical trial

A Multicenter Single-Arm Objective Performance Criteria Trial to Determine the Efficacy and Safety of High-Frequency Irreversible Electroporation as Primary Treatment for Localized Prostate Cancer: A Study Protocol

Irreversible Electroporation for the Focal Treatment of Prostate Cancer: A Systematic Review

Efficacy and Safety of Ultrasonography Guided Transperineal Percutaneous Laser Ablation for Treating Benign Prostatic Hyperplasia: A Randomized Controlled Clinical Trial Compared with Transurethral Resection of the Prostate

A Multicenter, Randomized, Single-blind, 2-Arm Intervention Study Evaluating the Adverse Events and Quality of Life After Irreversible Electroporation for the Ablation of Localized Low-intermediate Risk Prostate Cancer

Study on the efficacy and safety of Transurethral enucleation and resection of the prostate in treatment of IV grade Benign prostatic hyperplasia

Efficacy and Safety of Bipolar Plasma Vaporization of the Prostate with "Button-Type" Electrode Compared with Transurethral Resection of Prostate for Benign Prostatic Hyperplasia.

Non-inferiority, randomised, open-label clinical trial on the effectiveness of transurethral microwave thermotherapy compared to prostatic artery embolisation in reducing severe lower urinary tract symptoms in men with benign prostatic hyperplasia: study protocol for the TUMT-PAE-1 trial

Personalized Treatment Strategy in “Low-Risk Prostate Cancer Active Surveillance Candidates” Using Irreversible Electroporation: Prospective Evaluation of Feasibility, Morbidity, Functional and Oncological Outcomes

A Prospective, Randomised Trial Comparing Transurethral Enucleation with Bipolar System (TUEB) to Monopolar Resectoscope Enucleation of the Prostate for Symptomatic Benign Prostatic Hyperplasia

Efficacy of electrical pudendal nerve stimulation versus pelvic floor muscle training in treating postradical prostatectomy urinary incontinence: study protocol for a randomised controlled trial

Radiation therapy and IRreversible electroporation for intermediate risk prostate cancer (RTIRE)

Bipolar Transurethral Enucleation and Resection of the Prostate Versus Bipolar Resection of the Prostate for Prostates Larger Than 60gr: A Retrospective Study at a Single Academic Tertiary Care Center

Effect of Focal Vs Extended Irreversible Electroporation for the Ablation of Localized Low- or Intermediate-Risk Prostate Cancer on Early Oncological Control A Randomized Clinical Trial

Transurethral enucleation of the prostate versus transvesical open prostatectomy for large benign prostatic hyperplasia: a systematic review and meta-analysis of randomized controlled trials

Oncological and Quality-of-life Outcomes Following Focal Irreversible Electroporation as Primary Treatment for Localised Prostate Cancer: A Biopsy-monitored Prospective Cohort

Biofeedback combined with percutaneous electrical pudendal nerve stimulation for the treatment of low anterior rectal resection syndrome: a study protocol for a randomized controlled trial

A multi-center international study to evaluate the safety, functional and oncological outcomes of irreversible electroporation for the ablation of prostate cancer

Irreversible electroporation as a focal therapy for localized prostate cancer: A systematic review

Bipolar transurethral resection versus monopolar transurethral resection for benign prostatic hypertrophy: a systematic review and meta-analysis.